Mitochondria in Diabetic Kidney Disease
Diabetic kidney disease (DKD) is the leading cause of end stage renal disease (ESRD) in the USA. The pathogenesis of DKD is multifactorial and involves activation of multiple signaling pathways with merging outcomes including thickening of the basement membrane, podocyte loss, mesangial expansion, t...
Guardado en:
Autores principales: | , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
MDPI AG
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/fa1ef0bc8b8341198e53cc208d328531 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:fa1ef0bc8b8341198e53cc208d328531 |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:fa1ef0bc8b8341198e53cc208d3285312021-11-25T17:09:34ZMitochondria in Diabetic Kidney Disease10.3390/cells101129452073-4409https://doaj.org/article/fa1ef0bc8b8341198e53cc208d3285312021-10-01T00:00:00Zhttps://www.mdpi.com/2073-4409/10/11/2945https://doaj.org/toc/2073-4409Diabetic kidney disease (DKD) is the leading cause of end stage renal disease (ESRD) in the USA. The pathogenesis of DKD is multifactorial and involves activation of multiple signaling pathways with merging outcomes including thickening of the basement membrane, podocyte loss, mesangial expansion, tubular atrophy, and interstitial inflammation and fibrosis. The glomerulo-tubular balance and tubule-glomerular feedback support an increased glomerular filtration and tubular reabsorption, with the latter relying heavily on ATP and increasing the energy demand. There is evidence that alterations in mitochondrial bioenergetics in kidney cells lead to these pathologic changes and contribute to the progression of DKD towards ESRD. This review will focus on the dialogue between alterations in bioenergetics in glomerular and tubular cells and its role in the development of DKD. Alterations in energy substrate selection, electron transport chain, ATP generation, oxidative stress, redox status, protein posttranslational modifications, mitochondrial dynamics, and quality control will be discussed. Understanding the role of bioenergetics in the progression of diabetic DKD may provide novel therapeutic approaches to delay its progression to ESRD.Amna Ayesha AhmadShayna Odeal DravesMariana RoscaMDPI AGarticlediabetesdiabetic kidney diseasemitochondriabioenergeticsredox statusBiology (General)QH301-705.5ENCells, Vol 10, Iss 2945, p 2945 (2021) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
diabetes diabetic kidney disease mitochondria bioenergetics redox status Biology (General) QH301-705.5 |
spellingShingle |
diabetes diabetic kidney disease mitochondria bioenergetics redox status Biology (General) QH301-705.5 Amna Ayesha Ahmad Shayna Odeal Draves Mariana Rosca Mitochondria in Diabetic Kidney Disease |
description |
Diabetic kidney disease (DKD) is the leading cause of end stage renal disease (ESRD) in the USA. The pathogenesis of DKD is multifactorial and involves activation of multiple signaling pathways with merging outcomes including thickening of the basement membrane, podocyte loss, mesangial expansion, tubular atrophy, and interstitial inflammation and fibrosis. The glomerulo-tubular balance and tubule-glomerular feedback support an increased glomerular filtration and tubular reabsorption, with the latter relying heavily on ATP and increasing the energy demand. There is evidence that alterations in mitochondrial bioenergetics in kidney cells lead to these pathologic changes and contribute to the progression of DKD towards ESRD. This review will focus on the dialogue between alterations in bioenergetics in glomerular and tubular cells and its role in the development of DKD. Alterations in energy substrate selection, electron transport chain, ATP generation, oxidative stress, redox status, protein posttranslational modifications, mitochondrial dynamics, and quality control will be discussed. Understanding the role of bioenergetics in the progression of diabetic DKD may provide novel therapeutic approaches to delay its progression to ESRD. |
format |
article |
author |
Amna Ayesha Ahmad Shayna Odeal Draves Mariana Rosca |
author_facet |
Amna Ayesha Ahmad Shayna Odeal Draves Mariana Rosca |
author_sort |
Amna Ayesha Ahmad |
title |
Mitochondria in Diabetic Kidney Disease |
title_short |
Mitochondria in Diabetic Kidney Disease |
title_full |
Mitochondria in Diabetic Kidney Disease |
title_fullStr |
Mitochondria in Diabetic Kidney Disease |
title_full_unstemmed |
Mitochondria in Diabetic Kidney Disease |
title_sort |
mitochondria in diabetic kidney disease |
publisher |
MDPI AG |
publishDate |
2021 |
url |
https://doaj.org/article/fa1ef0bc8b8341198e53cc208d328531 |
work_keys_str_mv |
AT amnaayeshaahmad mitochondriaindiabetickidneydisease AT shaynaodealdraves mitochondriaindiabetickidneydisease AT marianarosca mitochondriaindiabetickidneydisease |
_version_ |
1718412690027708416 |